307 related articles for article (PubMed ID: 28685356)
1. Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series.
Ohgi K; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Aramaki T; Uesaka K
Ann Surg Oncol; 2017 Sep; 24(9):2752-2761. PubMed ID: 28685356
[TBL] [Abstract][Full Text] [Related]
2. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
[TBL] [Abstract][Full Text] [Related]
3. National Comprehensive Cancer Network Resectability Status for Pancreatic Carcinoma Predicts Overall Survival.
Murakami Y; Satoi S; Sho M; Motoi F; Matsumoto I; Kawai M; Honda G; Uemura K; Yanagimoto H; Shinzeki M; Kurata M; Kinoshita S; Yamaue H; Unno M
World J Surg; 2015 Sep; 39(9):2306-14. PubMed ID: 26013206
[TBL] [Abstract][Full Text] [Related]
4. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion.
Wang WL; Ye S; Yan S; Shen Y; Zhang M; Wu J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):429-35. PubMed ID: 26256089
[TBL] [Abstract][Full Text] [Related]
5. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.
Mierke F; Hempel S; Distler M; Aust DE; Saeger HD; Weitz J; Welsch T
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501
[TBL] [Abstract][Full Text] [Related]
6. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
[TBL] [Abstract][Full Text] [Related]
7. Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portosplenomesenteric venous invasion.
Okabayashi T; Shima Y; Iwata J; Morita S; Sumiyoshi T; Kozuki A; Saisaka Y; Tokumaru T; Iiyama T; Noda Y; Hata Y; Matsumoto M
Langenbecks Arch Surg; 2015 May; 400(4):487-94. PubMed ID: 25940756
[TBL] [Abstract][Full Text] [Related]
8. Preoperative defining system for pancreatic head cancer considering surgical resection.
Yang SJ; Hwang HK; Kang CM; Lee WJ
World J Gastroenterol; 2016 Jul; 22(26):6076-82. PubMed ID: 27468199
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
[TBL] [Abstract][Full Text] [Related]
10. Inferior Infracolic 'Superior Mesenteric Artery First' Approach with a No-Touch Isolation Surgical Technique in Patients with a Borderline Resectable Cancer of the Pancreatic Head.
Zhu J; Han D; Li X; Pan F; Ma J; Kou J; Fan H; Lang R; He Q
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):976-980. PubMed ID: 27600620
[TBL] [Abstract][Full Text] [Related]
11. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of the length of tumour-vein contact at the portal-superior mesenteric vein in patients having surgery for pancreatic cancer.
Imamura T; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Todaka A; Fukutomi A; Aramaki T; Uesaka K
Br J Surg; 2019 Nov; 106(12):1649-1656. PubMed ID: 31626342
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
[TBL] [Abstract][Full Text] [Related]
14. Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer.
Kato Y; Yamada S; Tashiro M; Sonohara F; Takami H; Hayashi M; Kanda M; Kobayashi D; Tanaka C; Nakayama G; Koike M; Fujiwara M; Kodera Y
HPB (Oxford); 2019 Sep; 21(9):1211-1218. PubMed ID: 30773450
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic adenocarcinoma with histologically proven portal vein infiltration: what is the outcome?
Martin D; Petermann D; Fontanella S; Pu Y; Halkic N; Demartines N; Schäfer M
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1507-1513. PubMed ID: 30222630
[TBL] [Abstract][Full Text] [Related]
16. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.
Wittel UA; Lubgan D; Ghadimi M; Belyaev O; Uhl W; Bechstein WO; Grützmann R; Hohenberger WM; Schmid A; Jacobasch L; Croner RS; Reinacher-Schick A; Hopt UT; Pirkl A; Oettle H; Fietkau R; Golcher H
BMC Cancer; 2019 Oct; 19(1):979. PubMed ID: 31640628
[TBL] [Abstract][Full Text] [Related]
17. Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma.
Murakami Y; Satoi S; Motoi F; Sho M; Kawai M; Matsumoto I; Honda G;
Br J Surg; 2015 Jun; 102(7):837-46. PubMed ID: 25877050
[TBL] [Abstract][Full Text] [Related]
18. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.
Tran Cao HS; Balachandran A; Wang H; Nogueras-González GM; Bailey CE; Lee JE; Pisters PW; Evans DB; Varadhachary G; Crane CH; Aloia TA; Vauthey JN; Fleming JB; Katz MH
J Gastrointest Surg; 2014 Feb; 18(2):269-78; discussion 278. PubMed ID: 24129826
[TBL] [Abstract][Full Text] [Related]
19. Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic cancer.
Ravikumar R; Sabin C; Abu Hilal M; Al-Hilli A; Aroori S; Bond-Smith G; Bramhall S; Coldham C; Hammond J; Hutchins R; Imber C; Preziosi G; Saleh A; Silva M; Simpson J; Spoletini G; Stell D; Terrace J; White S; Wigmore S; Fusai G
Br J Surg; 2017 Oct; 104(11):1539-1548. PubMed ID: 28833055
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic neck cancer has specific and oncologic characteristics regarding portal vein invasion and lymph node metastasis.
Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yamaue H
Surgery; 2016 Feb; 159(2):426-40. PubMed ID: 26253244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]